SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001513160-11-000010
Filing Date
2011-03-25
Accepted
2011-03-25 19:37:58
Documents
1
Period of Report
2011-02-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1423
  Complete submission text file 0001513160-11-000010.txt   2907
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 4731 Arrangement of Transportation of Freight & Cargo

Mailing Address 817 LEVERING AVENUE UNIT 8 LOS ANGELES CA 90024
Business Address
Coles L. Stephen (Reporting) CIK: 0001516718 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-53127 | Film No.: 11713671